Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma

作者：Pei Ma, Haoyang Shen, Dongsheng Chen, Zhongyu Lu, Wen Gao, Yongqian Shu · 发表于：Oral Oncology · 年份：2022 · DOI：10.1016/j.oraloncology.2022.105905 · 被引用次数：4 · 研究领域：Salivary Gland Tumors Diagnosis and Treatment、Head and Neck Cancer Studies、Ear and Head Tumors